Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Long-term Investment Intensity

Latest as of September 2019: 14.4%

Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Long-term Investment Intensity of 14.4% as of September 2019. Long-term investments of CN¥1.55 Billion represent 14.4% of total assets of CN¥10.77 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Zhejiang CONBA Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

14.4%
LT Investments / Total Assets

Long-term Investments

CN¥1.55 Billion
CNY

Total Assets

CN¥10.77 Billion
CNY

Country

China
SHG

Zhejiang CONBA Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Zhejiang CONBA Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 14.4%, reflecting long-term investments of CN¥1.55 Billion against total assets of CN¥10.77 Billion CNY. For the complete balance sheet picture, see 600572 total assets.

Annual Long-term Investment Intensity for Zhejiang CONBA Pharmaceutical Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Zhejiang CONBA Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Zhejiang CONBA Pharmaceutical Co Ltd (600572) total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 14.7% CN¥1.58 Billion CN¥10.71 Billion ▲ +8.4 pp
2017 6.3% CN¥597.97 Million CN¥9.42 Billion ▼ -0.7 pp
2016 7.1% CN¥600.72 Million CN¥8.50 Billion ▲ +2.6 pp
2015 4.5% CN¥430.40 Million CN¥9.57 Billion
pp = percentage points